Skip to main content
. 2018 Aug 21;8:323. doi: 10.3389/fonc.2018.00323

Table 1.

Analysis of the study subjects.

Patients analyzed (Total = 279) Patients with mutation (n) Age range Age mean ± SD
Healthy women 9 40–58 47.7 ± 5.3
Healthy men 2 47 & 76 61.5 ± 20.5
Breast cancer women 34 28–72 41.6 ± 9.3
Breast cancer men 3 59–75 65 ± 7.3
Ovary cancer 7 41–77 60.6 ± 13.3
Breast and ovary 6
   Breast 35–46 40.4 ± 5.2
   Ovary 41–60 47.8 ± 7.2
Total with a mutation 61 (27.6%)*
*

AJ mutations 55/279 (19.7%); Non-AJ mutations 6/76 (7.9%).